Platelet-rich plasma in the treatment of knee osteoarthritis: a randomized, double-blinded, controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025005

Enrollment

Unknown

Registered

2019-08-07

Start date

2019-08-15

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

platelet-rich plasma(PRP):PRP

hyaluronic acid:hyaluronic acid

NS:saline solution

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with knee osteoarthritis.

Exclusion criteria

Exclusion criteria: 1. Patient aged less than 18 years; 2. History of knee operations; 3. History of knee intra-articular injections or oral NASID in the past 6 months; 4. Unable to receive pre-treatment assessment and post-treatment follow-up; 5. Patients with blood diseases.

Design outcomes

Primary

Measure	Time frame
WOMAC scores;	—

Countries

China

Contacts

Public ContactLiu Yan

West China Hospital, Sichuan University

123315971@qq.com+86 18190030357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026